Sixteen drugmakers limiting discounts:
1. AbbVie
2. Amgen
3. AstraZeneca
4. Boehringer Ingelheim
5. Eli Lilly
6. Merck
7. Novartis
8. Novo Nordisk
9. Sanofi
10. UCB
11. United Therapeutics
12. Bristol Myers Squibb
13. Pfizer
14. GlaxoSmithKline
15. Gilead
16. Johnson & Johnson
“These limits reduce resources available to safety-net providers and increase the size of drug company profits. The biggest losers in this dispute are low-income and rural Americans who rely on the healthcare safety net for care when they are sick and preventive services to keep them healthy,” said Maureen Testoni, CEO and president of 340B Health.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
